Previous
Next
July 21, 2015

At the International AIDS Society (IAS) Conference today, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warned that middle-income countries (MICs), which will be home to 70 per cent of people living with HIV by 2020, face increasing threats to their ability to access affordable generic medicines, which are crucial to countries’ ability to reach the global UNAIDS 90/90/90* targets.

July 20, 2015

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warned today that not enough is being done to ensure that people with HIV/AIDS who are on antiretroviral treatment (ART) reach and maintain “undetectable” levels of virus in their blood.

July 20, 2015

The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) applauds the results of the Strategic Timing of Antiretroviral Treatment (START) trial, released today at the International AIDS Society Conference (IAS) in Vancouver, showing that immediate treatment is beneficial for the individual regardless of the status of his or her immune system.